This bill amends section 28-470 of the Revised Statutes Cumulative Supplement, 2024, to enhance immunity provisions for individuals involved in administering opioid overdose reversal medications, specifically naloxone. The bill allows health professionals authorized to prescribe or dispense opioid overdose reversal medications to do so without facing administrative action or criminal prosecution when acting with reasonable care. It also extends this immunity to family members, friends, and other individuals, including school personnel, who assist someone experiencing an opioid-related overdose, provided they act in good faith.

Additionally, the bill introduces a new definition for "opioid overdose reversal medication," which encompasses any lifesaving medication approved by the FDA for reversing an opioid overdose, including naloxone and nalmefene. The language regarding naloxone is updated to reflect this broader definition. The bill repeals the original section 28-470, thereby consolidating the changes into a single, updated statute. Overall, the legislation aims to encourage the use of opioid overdose reversal medications by providing legal protections to those who administer them in emergency situations.

Statutes affected:
Introduced: 28-470